Trials / Terminated
TerminatedNCT03923010
A Study of Itraconazole in the Management of Superficial Fungal Infections in India
Itraconazole in the Management of Superficial Fungal Infections in India. A Pilot Study
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to estimate the proportion of participants prescribed itraconazole for Tinea cruris or Tinea corporis who have clinical response after 7 days of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Itraconazole | Participants will receive itraconazole 200 mg orally once daily for 7 days and at the discretion of the treating physician on Day 14. Participants will also get their regular clinical care at the discretion of their treating physician. |
Timeline
- Start date
- 2019-08-06
- Primary completion
- 2020-03-25
- Completion
- 2020-03-27
- First posted
- 2019-04-22
- Last updated
- 2021-09-01
Locations
4 sites across 1 country: India
Source: ClinicalTrials.gov record NCT03923010. Inclusion in this directory is not an endorsement.